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Research
AbstrACt
Objectives To compare parents’ and clinicians’ 
perspectives on the assessment and treatment of children 
with eczema in primary care.
Design Qualitative interview study with purposive and 
snowball sampling and thematic analysis.
setting 14 general practices in the UK.
Participants 11 parents of children with eczema and 15 
general practitioners (GPs) took part in semistructured 
individual interviews.
results We identified several areas of dissonance 
between parents and GPs. First, parents sought a ‘cause’ 
of eczema, such as an underlying allergy, whereas GPs 
looked to manage the symptoms of an incurable condition. 
Second, parents often judged eczema severity in terms 
of psychosocial impact, while GPs tended to focus on the 
appearance of the child’s skin. Third, parents sought ‘more 
natural’ over-the-counter treatments or complementary 
medicine, which GPs felt unable to endorse because of 
their unknown effectiveness and potential harm. Fourth, 
GPs linked poor outcomes to unrealistic expectations 
of treatment and low adherence to topical therapy, 
whereas parents reported persisting with treatment and 
despondency with its ineffectiveness. Consultations were 
commonly described by parents as being dominated by the 
GP, with a lack of involvement in treatment decisions. GPs’ 
management of divergent views varied, but avoidance 
strategies were often employed.
Conclusions Divergent views between parents and 
clinicians regarding the cause and treatment of childhood 
eczema can probably only be bridged by clinicians 
actively seeking out opinions and sharing rationale for 
their approach to treatment. Together with assessing the 
psychosocial as well as the physical impact of eczema, 
asking about current or intended use of complementary 
therapy and involving parents in treatment decisions, the 
management of eczema and patient outcomes could be 
improved.
IntrODuCtIOn
Eczema is a common childhood condi-
tion characterised by dry and itchy skin.1 
However, due to the fluctuating nature of the 
condition, carers must adapt their treatment 
regimen according to the child’s symptoms 
and the appearance of the skin. Emollients 
are usually used in the maintenance phase 
and different-strength topical corticosteroids 
(TCS) or calcineurin inhibitors are used to 
treat an exacerbation or ‘flare’. Consequently, 
treatment regimens can become complex 
and poor adherence has been associated with 
poor clinical outcomes.1 
Factors affecting treatment adherence and 
outcomes in childhood eczema include: the 
time taken to apply treatments; confusion 
about what, when and how to use prescribed 
medications2 and parental fear of TCS side 
effects.3 4 The doctor–patient relationship is a 
key factor influencing treatment outcomes.2 
Good verbal and non-verbal communica-
tion, shared decision-making, practitioner 
interest in the patient and acknowledgement 
of psychosocial issues contribute to a more 
positive relationship which in turn can lead 
to improved treatment adherence.2 Parents’ 
views of and approach to eczema treatments 
may be different to those of a clinician. In the 
UK, most children with eczema are managed 
in primary care yet parents can feel that the 
condition is not taken seriously enough by 
their general practitioner (GP).5 However, 
research in this area has focused on the views 
and experiences of parents and children and 
the perspective of primary care clinicians, 
strengths and limitations of this study
 ► First qualitative study to directly explore and 
compare general practitioner (GP) and parent 
perspectives around eczema management.
 ► Diverse sample of GPs and parents.
 ► Several GPs had a personal or professional interest 
in eczema.
 ► Paired interviews may have given a better 
understanding of areas of divergent views.
 ► As secondary findings to the main research 
questions, these themes require further exploration.
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and particularly the interaction between GP and patient 
has not been examined in any detail.
As part of a wider study to develop an eczema written 
action plan (WAP)6 for children, we explored the expe-
riences of managing eczema from a range of perspec-
tives. In a previous publication, we described the clinical 
perspective in relation to training, diagnosis and treat-
ment.7 In this paper, to better understand the issues and 
their impact on the care of children with eczema more 
generally, we extend this analysis by comparing for the 
first time the contrasting views of GPs and parents.
MethODs
Qualitative interview study to identify the experience of 
managing childhood eczema in primary care from the 
perspective of GPs and parents.
recruitment and sampling
We interviewed GPs and parents of children under 
12 years with eczema, the age group representing the 
majority of eczema cases in primary care.8 Parents 
were recruited from five socioeconomically diverse GP 
surgeries by written invitation and sampled by the child’s 
age, gender and ethnicity, and self-reported eczema 
severity.9 Children were given the opportunity to partici-
pate in the interview at their parents’ discretion. GPs were 
recruited from the same practices and through personal 
and professional networks. They were sampled by gender, 
years in job role, experience of using and perceived value 
of WAPs for eczema, and sociodemographic area of the 
practice. Parents’ Index of Multiple Deprivation (IMD) 
were obtained using their home postal code.10
Data collection
Data collection took place between May 2016 and February 
2017. All participants gave written informed consent to 
take part in the study. Interviews lasted typically between 
45 and 60 min, and took place in participants’ homes, on 
National Health Service premises or by telephone. The 
interviewers (KP, a non-clinical researcher and ELR, a 
GP with a specialist interest in dermatology) used a topic 
guide specific for each participant group (ie, parents and 
GPs) to facilitate discussion. The initial versions were 
based on the findings of a qualitative and quantitative 
literature review of self-management/WAPs in children 
with long-term conditions/eczema.11 12 In discussion with 
the research team, they were refined iteratively over the 
course of the study, as new areas warranting further explo-
ration emerged. Table 1 shows the issues covered that are 
relevant to the findings in this paper. ELR interviewed 
most of the GPs (13/15) and KP interviewed all of the 
parents. To minimise any biases, both researchers wrote 
reflective and reflexive accounts throughout the inter-
views and we discussed any issues with the study team, 
made up of both clinical and non-clinical researchers, at 
regular team meetings. KP and ELR also independently 
double coded a sample of the transcripts (see Data anal-
ysis section). Data collection ended once we achieved data 
saturation within the parent and GP groups with respect 
to the main research questions around developing a 
WAP. While the main research question was focused on 
the WAP development, this was underpinned by identi-
fying issues that parents and children face in primary care 
consultations and therefore the findings presented in this 
paper were a key element of our data collection.
Data analysis
All interview transcripts were transcribed verbatim and 
imported into QSR NVivo V.10 software. A coding frame-
work, as part of the constant comparative thematic anal-
ysis approach,13 was developed and refined by KP and 
ELR alongside data collection and agreed with the wider 
study team. KP and ELR separately applied the coding 
framework (see online supplementary appendix A) to 
eight transcripts and discussed and resolved any discrep-
ancies to maximise inter-rater coding agreement. Themes 
were developed by line-by-line analyses and coding of the 
data which led to clear patterns in the data from both 
parents and GPs. Codes were compared within and across 
participant groups and then grouped into themes and 
subthemes.
Patient and public involvement
Between two and four parents met three times in 
1.5–2 hours small group meetings over the duration of the 
broader study. As part of the development of the eczema 
WAP, they were invited to comment on the findings. They 
reported that the ‘barriers to treatment’ described in this 
paper had strong face validity.
results
We interviewed 11 parents (2 with children) and 15 GPs. 
Participant characteristics are shown in table 2. Of the 
doctors, 10 were GP partners and 5 associates; two had 
Table 1 Topic guide questions around experience of managing eczema
Parents General practitioners
 ►What difficulties have you encountered around diagnosis/
treatment?
 ►What treatments have you used?
 ►What advice/support have been given?
 ►What follow-up have you received?
 ►What difficulties have you encountered around diagnosis/
treatment?
 ►What advice do you give and what do you prescribe?
 ►What follow-up arrangements do you make?
 ► How do you try and support parents in looking after their 
child?
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a specialist interest in dermatology and two declared a 
personal experience of eczema (family member affected). 
Their mean self-reported confidence in managing 
eczema (0 low, 10 high) was 7.3 (range 5–9). Participating 
parents’ children had a mean eczema severity score of 
15.3 (range 1–27), based on the Patient-Oriented Eczema 
Measure9 (based on the most affected child for 10 of the 
11 parents). Parents had an mean IMD of 5.2 (range 1–9; 
1, low, 10 high).
Parents and GPs had different perspectives on the 
causes, impact and treatment of the condition. We 
explore the divergent perspectives between parent and 
GP across several dimensions of primary care consulta-
tions for childhood eczema, including assessment, treat-
ment options and treatment adherence/efficacy.
Divergent views about assessment and cause
One area of division between GPs and parents was around 
the assessment of the condition and its severity:
I think patients’ understanding of what bad eczema is 
often very different from ours so sometimes they say 
oh it’s a terrible rash and, you know, it’s the faintest, 
palest little bit of redness so because they haven’t ever 
seen the severity of what eczema can be (019G:GP).
In describing the condition, GPs focused more on the 
physical appearance of eczema and symptoms such as 
scratching and disturbed sleep. In comparison, parents 
emphasised the wider psychosocial impact of eczema on 
the family, social activities and emotional well-being:
 there’s no way we could even contemplate camping. 
There’s sort of limits- every single night they’ve got 
to have a bath, its- he can’t have a normal life but 
don’t get me wrong, it’s not life threatening and, you 
know, compared with what he could have its amazing 
but people have no idea, they haven’t got a clue the 
impact it has. (025P:parent).
Parents felt this wider impact was often overlooked/
underestimated by GPs:
You kind of go in and the doctor thinks oh child’s 
a bit itching, they’re not sleeping, rah rah rah, is 
this just a parent who is being over reactive when in 
reality you’ve got a screaming child who is crawling at 
their skin (034P:parent).
There were also differing views between parents and 
GPs about the cause of eczema. Parents often spoke of 
seeking a ‘cure’ and held beliefs about an underlying, 
remediable cause to their child’s eczema, most commonly 
allergy, whereas GPs approached it as an incurable, long-
term condition:
 when a child is suffering from the eczema the main 
thing we have to focus on what causes it. It could 
be for definite it was the diet, it was like allergic to 
food… (018P:parent)
I don’t think they find it difficult to accept that this is 
called eczema. I think its difficulties accepting that it 
will be chronic and they will have a tendency to it and 
accepting that’s it not caused by something that they 
can treat and then it will go away. (021G:GP)
GPs spoke of the challenge of addressing these parental 
beliefs and resolving discrepant perspectives:
I think they expect that if they can find the one trig-
ger for the eczema they can make it all magically go 
away so you have to unpick that. (041G:GP).
Managing divergent views around allergy and 
complementary/alternative medicine
GPs described how in addition to managing the child’s 
condition, they ‘managed’ parent views about allergy 
testing and non-prescribed treatments. GPs noted that 
parents commonly voiced concerns about allergy during 
consultations. The difficulty for GPs was weighing up 
parents’ concerns against the clinical likelihood of an 
allergy, the poor accuracy of the tests and concern about 
overloading the allergy services:
You take a food history and see if there are any trig-
gers but if they can’t usually identify any I don’t tend 
to pursue that. I don’t know if that’s good practice 
or not to be honest but it’s my general approach to 
things. (030G:GP).
Strategies to manage this tension varied. Some GPs 
spoke of acknowledging parents’ beliefs (“trying to under-
stand what their concern is” (017G), or taking an allergy 
focused history to identify a potential problem and, if not, 
diplomatically explaining that allergy is unlikely to be a 
factor. Others spoke of trying to “steer” (031G) parents 
away from this idea and “encourage them to stick to the 
mainstay” (021G), that is , controlling it with emollients:
I try and explore what they think allergy testing is and 
what they think they will achieve by having it and ulti-
mately when they- what they’re actually asking for is a 
referral to a specialist which is in some cases entirely 
fair enough but I think as I said I think they come 
in armed with a lot of misinformation about it and 
kind of hope that it’s the holy grail which you can 
Table 2 Participant characteristics
General 
practitioners Parents Child
Mean age in years 
(range)
43.6 (30–56) 37.4 (27–48) 5.3 (0–11)
Mean years in role 
(range)
14.1 (0.5–29) – – 
Gender
  Male 4 0 4
  Female 11 11 7
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completely understand, but, yeah, I think it’s a slight-
ly murky field (041G:GP).
When parents in our study had raised concerns about 
allergy, they said they were happy to take their GPs’ advice. 
However, they had difficulty reconciling this advice when 
it conflicted with that received from other sources such as 
the internet and peers:
I: ‘Is there anything else that would have helped you 
during that time?
P: ‘Yes, to get a concise answer on whether allergy 
testing is worth doing or not ‘cos the number of peo-
ple who’ve said to me over the years oh well when 
I had eczema or my, you know, seventh cousin re-
moved had eczema then they cut out this, that and 
the other, if I’d followed all of that he would eat noth-
ing at all and yet I’ve always been told by the medical 
profession we don’t allergy test children with ecze-
ma because sometimes they’ll react, sometimes they 
won’t…’ (025P:parent).
One parent reported that the GP ‘dismissed’ their 
concern about allergy:
My son is allergic to dairy but she [daughter] isn’t but 
I did say to the GP could it be that she shouldn’t have 
dairy and she said- she just dismissed that and said no 
but I- it’s difficult isn’t it? I don’t know the evidence 
about, you know, allergies and skin conditions….if 
there is research about diet and eczema I’d like to 
know about that (028P:parent).
Parents understood ‘complementary and alterna-
tive’ treatments differently. Some talked about products 
bought over-the-counter (OTC), such as moisturisers and 
coconut oil,  which was common place; while others talked 
of herbal remedies and acupuncture, hereon referred 
to as CAM (complementary and alternative medicine). 
Some parents turned to CAM in the hope of finding a 
cure, or in an attempt to better manage eczema symp-
toms, while for others it was about using more ‘natural’ 
products that they deemed to be safer for their child’s 
skin. Parents felt these therapies were effective and they 
wanted recognition of this from their clinician:
And also not dismissing, you know, if you are some-
body that wants to use more natural products on your 
child not to dismiss that, you know, as- for instance 
I use coconut oil for her cradle cap and that’s actu-
ally been amazing, you know, rather than using all 
these different shampoos. There are some natural 
things that really do work and, you know, you kind 
of want that holistic, you know, care for your child 
and just that that’s accepted in the medical world. 
(028P:parent).
GPs reported that use of OTC and CAM use among 
parents was common and uncommon, respectively, 
although one GP felt “we probably only know the fraction 
of it” (031G). They felt unable to endorse use of CAM 
or OTC products because of their unknown effectiveness 
and concerns about harmful additives:
Yeah, people talk about lots of other products, aloe 
vera comes up, but it’s difficult for me to assess wheth-
er- what the efficacy of those are so I tend to sort of 
gently, not sort of poo poo it but I gently steer them 
back to what I know works because I don’t always 
know what additives or product, you know, how good 
they are really (019G:GP).
 I know you’re not supposed to use the Chinese things 
anymore ‘cos they’ve probably got steroids in them 
aren’t they?’ (016G:GP)
GPs varied in whether they actively probed parents 
on their use of CAM or OTC products. One GP said she 
specifically asked parents, others said parents “ tend to 
come out with it” (035G), whilst for others still it was not 
“on the top of my list to actively ask” (031G:GP).
Parents and GPs agreed that limited time within the 
consultation was a contributory factor for these issues and 
concerns about allergy not being addressed:
in the ideal world, yes, me and my nurse we would be 
spending time explaining all of it but in the world we 
live in that’s impossible’ (015G:GP)
you only get like ten minutes with the doctor don’t 
you? It’s very brief, and they’ll say yes its eczema, 
here’s the cream, whack it on two to three times a 
week and then they send you out the door but you 
don’t know, like you say, it could be an allergy thing 
that started it off. (027P:parent).
treatment decisions, adherence and efficacy
GPs and parents reported a trial and error approach to 
finding an emollient that suited the family. Eczema guide-
lines advise healthcare professionals to offer parents 
and children a choice of emollients.1 14 15 While several 
GPs cited the importance of patient preference, their 
prescribing decisions around emollients seemed to be 
based on their own preferences or their experiences with 
other parents, rather than involving parents on an indi-
vidual basis:
So I tend to use quite a lot of Hydromol ointment 
‘cos from my own experience of my daughter found 
it really good… (035G:GP)
This mirrored the parents’ experiences of encounters 
with GPs, where their role in emollient choice was often 
depicted as passive compared with the directive manner 
of the GPs:
…the GP does his thing and I’m off with my big jars 
of moisturisers… (033P:parent)
…they’re like oh it’s just eczema, like you know chuck 
that at you and I, like I said, that’s the second dose 
now he’s had of that one… (014P:parent)
Poor treatment adherence in primary care was 
commonly reported among GPs. With TCS, they said it 
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was related to parental fear of their side effects, that is, 
skin thinning, which was corroborated by the parents 
themselves. With emollients, some GPs felt that it was a 
result of parents having unrealistic expectations:
they just want it fixed now, they’re not thinking to 
keep on applying, they’ll use it short term and then 
it’ll be ok and then they’ll come back. (029G:GP)
I think its difficulties accepting that it will be chron-
ic and they will have a tendency to it and accepting 
that’s it not caused by something that they can treat 
and then it will go away. (021G:GP).
Conversely, many parents reported persisting with 
topical therapy, but declared feelings of desperation and 
frustration at the futility of topical treatments due to their 
apparent inefficacy:
It just kept on getting worse and worse. I’ve used ev-
erything. I’ve used Oilatum, Aveeno, I’ve used derma- 
is it Dermatol or something like that for the head. 
I’ve used steroid creams but then I’ve just stopped us-
ing steroids because I looked at whenever they go- if 
it goes it comes back when you stop and it’s not really 
advised to use it for a long time anyway so what’s the 
point? (033P:parent)
Parents also described feelings of guilt about requesting 
more emollient from their GP, or said that requests were 
met with resistance:
Sometimes I have to fight my corner. I’ve now got it 
so that he gets- we get through 500 grams of hydro-
mol a day so at one point people would only give me 
enough to last barely a week. I’ve now got it so that 
we pick up sort of ten kilos a time. Yeah, sometimes- 
depending on who’s doing the repeat prescriptions 
you sometimes have to fight your corner a bit and 
I have to make sure I write a long letter to my GP if 
we’re going away for longer than a week or two to 
explain why I need ridiculous amounts of everything 
(025P:parent)
I feel a bit guilty asking for more prescriptions at the 
doctors (laughs) they must think oh I only did that, 
you know, a month ago or whatever. (028P:parent)
Despondency with topical therapy appeared to relate to 
parents’ lower confidence in clinicians who did not have 
specialist skills/knowledge. They described more confi-
dence in dermatologists and GPs with a specialist interest 
or training in dermatology as they felt they gave more 
credible advice, and treatments that ‘worked’:
for credibility, to believe what they tell- what they tell 
me, what they tell me works and I’m going to follow it 
I would want it to be someone who is trained by der-
matology or Eczema Society and does it frequently 
for other families. (000P:parent)
I think she just gave me a bit more information 
really and I trusted her experience of what is actually 
going to work … and she explained that eczema 
quite frequently gets infected and it would be better 
to use that (Dermol) regularly as her moisturiser 
(28P:parent).
DIsCussIOn
summary
We identified several areas of divergent views between 
parents and GPs regarding disease aetiology, assessment 
and treatment. First, parents looked for a ‘cure’ for 
eczema, often fixated on the role of allergy. Clinicians, 
on the other hand, were more focused on just ‘managing’ 
the condition. Second, some parents wanted clinicians 
to provide a more holistic approach to assessment and 
treatment, and to acknowledge the role of complemen-
tary or non-prescribed therapies. However, clinicians did 
not regularly enquire about use of non-prescribed treat-
ments and were not willing to support their use because 
of uncertainty about their provenance and absence 
of evidence regarding their efficacy or safety. Third, 
parents perceived GPs as dismissive and felt they did 
not recognise the full impact of eczema on the child’s 
quality of life. GPs felt that poor response to treatment 
was a result of lack of adherence to emollients, which 
was linked to parents wanting a quick ‘fix’. However, 
parents reported generally persisting with topical 
therapy but often felt it was ineffective. Finally, parents 
described GP–parent interactions as being dominated 
by the doctor, and the lack of parental involvement in 
treatment decisions was apparent in data from both 
perspectives.
strengths and limitations
To our knowledge, this is the first qualitative study to 
directly explore and compare GP and parent perspectives 
on eczema management and treatment. Our sample gave 
us a diverse range of views from parents (with respect to 
age, ethnicity of child and their self-rated eczema severity 
score) and GPs (with respect to age, years of working and 
sociodemographic population of the practice). However, 
GPs were predominantly female/GP partners and several 
had a professional or personal interest in eczema meaning 
the views captured may not be representative of all GPs. 
Despite this, our GP participants appeared to be unaware 
of the importance parents place on the wider impact of 
eczema, for example, the emotional and psychosocial 
elements. While some of the GPs and parents came from 
the same practice, the interviews were not ‘paired’. Paired 
interviews may have added to the richness of the data and 
our understanding of areas of divergence. The data may 
also have been influenced by the status of the interviewer; 
the majority of interviews with GPs were carried out by 
a GP researcher with a specialist interest in dermatology 
and the parent interviews by a non-clinical researcher.16 
Data gathered from the two children interviewed along-
side their parents are not presented because they did 
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not contribute any information around GP–patient 
dissonance.
Comparison with other literature
Patient resistance to topical treatments; perceived GP 
disinterest in eczema and its psychological impact; 
concerns about GP competency; and parental pursuit 
of allergy as cause and a ‘cure’ have been previously 
described.5 17 18 Gore et al19 outlined parents’ wide ranging 
and complex informational needs, including the require-
ment to address concerns about aetiology and any role 
for diet. However, we also found differences in parents’ 
and GPs’ approaches to assessing eczema, their views of 
the reasons for barriers to effective emollient therapy and 
their perspectives around CAM use.
Parents of children with eczema often want an ‘active’ 
role in treatment decision-making in order to address 
a perceived lack of (or inconsistent) information and 
the lack of time and/or interest from health profes-
sionals.19 Patients’ agendas are commonly not voiced 
which can lead to misunderstanding.20 Showing empathy 
and asking questions about the impact of the condition 
can positively affect the relationship between parent and 
GP,2 17 and is in line with current clinical guidance which 
advocates a holistic approach to eczema assessment.1 14 
However, our study shows that even when GPs are aware 
of disparate views, for example, parent beliefs around 
allergy, it does not necessarily result in discussion and reso-
lution of these beliefs. Rather, GPs described a tendency 
to avoid rather than confront them, with concerns about 
the access to, and interpretation of, allergy tests cited as 
factors.
Previous research suggests that CAM use is common 
among patients with eczema.21 22 Despite the risks attached 
to the use of some forms of CAM,23 it is promoted as 
being effective and safe,24 and is used by patients looking 
for ‘natural’ treatments and a ‘cure’,22 25 both of which 
were reasons for its use by parents in our study. Clinical 
guidelines encourage open discussions between health-
care professionals and parents about CAM treatments for 
eczema and explanations about the lack of evidence for 
its safety and efficacy.1 14 However, patients rarely disclose 
CAM use26 and healthcare professionals rarely ask about 
it.27 28 Similarly in our study, conversations about CAM 
were not high on the GPs’ agenda, which may partly be 
due to their perception that it is not commonly used for 
eczema.
Another reported reason for CAM use is patient dissat-
isfaction with conventional eczema treatments,22 where 
parents sometimes feel emollients do not ‘work’.5 This 
was reflected in our interviews with parents where they 
persisted with topical therapy but often felt it was inef-
fective. Santer et al29 found that parents had mixed views 
about long-term use of emollients to prevent flare-ups 
and this was echoed by the GPs in our study who said that 
parents were not using emollients for long enough to be 
effective and were expecting results with short-term use. 
Education about the rationale for emollients may lead to 
more positive parental attitudes towards long-term use.29 
Emollients are widely accepted in the medical world as the 
mainstay for eczema management in that they are the first 
line of treatment even when the skin is clear.30 They come 
in different formulations, but there is limited evidence to 
support the use of one emollient over another, therefore 
patient preference is a key part of prescribing decisions.31 
However, the other key treatment in primary care for chil-
dren with all but the mildest eczema is appropriate use of 
TCS, concerns about which can be a significant barrier to 
achieving and maintaining disease control.5 32
Implications for research and practice
Good eczema care requires a significant degree of 
self-management but engagement in such processes 
needs to be built on a solid foundation of understanding 
around causes and treatment between GP and parent. 
Rather than shying away from these conversations, clini-
cians should be prepared to engage in these discussions 
and explain the rationale behind their approach. Longer, 
initial consultations may facilitate this, although this 
must be accompanied by skills and knowledge that builds 
parental trust. There is some evidence that nurse-led 
clinics may improve eczema control which could be used 
to support time-limited GPs, although evidence of benefit 
in a primary care setting is lacking.11
Clinicians are reminded that assessments of disease 
severity should include questions about psychoso-
cial impact as well as a physical examination. Better 
shared decision-making, particularly around treatment 
preferences, together with signposting of reliable sources 
of information may also improve treatment adherence. 
As evidence to guide emollient choice and the long-
term safety of TCS is lacking,33 healthcare professionals 
and parents need to openly discuss individual needs and 
preferences to find a treatment that is both suitable and 
acceptable for the family. Treatment discussions should 
also include current or intended use of CAM as parents 
may be unaware of its potential risks. Understanding 
why a parent is using CAM, for example because they 
are dissatisfied with their emollient, may inform future 
prescribing decisions.
Our work, and that of others, could be extended 
through observation of consultations, to assess how these 
divergent perspectives are played out in practice and how 
they might be addressed. In addition to supporting GP 
undergraduate and postgraduate dermatology education, 
research is needed to find ways to support consultations 
in primary care for eczema. The WAP, we have developed 
as part of the wider project, may be one way of facilitating 
these discussions.6
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